These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15699751)
1. Long-term benefit of mycophenolate mofetil in renal transplantation. Lang P; Pardon A; Audard V Transplantation; 2005 Feb; 79(3 Suppl):S47-8. PubMed ID: 15699751 [TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Sollinger HW Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033 [TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group. Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543 [TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group. Mycophenolate Mofetil Acute Renal Rejection Study Group Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408 [TBL] [Abstract][Full Text] [Related]
5. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181 [TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Ojo AO; Meier-Kriesche HU; Hanson JA; Leichtman AB; Cibrik D; Magee JC; Wolfe RA; Agodoa LY; Kaplan B Transplantation; 2000 Jun; 69(11):2405-9. PubMed ID: 10868649 [TBL] [Abstract][Full Text] [Related]
7. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation. Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583 [TBL] [Abstract][Full Text] [Related]
8. [Use of mycophenolate mofetil in kidney transplantation]. Hrvacevic R; Ignjatovic Lj; Vavic N Vojnosanit Pregl; 2001; 58(4):415-9. PubMed ID: 11712223 [TBL] [Abstract][Full Text] [Related]
9. Treatment of severe acute vascular rejection in a renal allograft with mycophenolate mofetil and high dose steroids. Lafferty ME; Lang S; McGregor E; Henderson IS; Jones MC Scott Med J; 1997 Jun; 42(3):79-80. PubMed ID: 9351121 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Knight SR; Russell NK; Barcena L; Morris PJ Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178 [TBL] [Abstract][Full Text] [Related]
11. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Mathew TH Transplantation; 1998 Jun; 65(11):1450-4. PubMed ID: 9645801 [TBL] [Abstract][Full Text] [Related]
12. Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil. Ferraris JR; Ghezzi LF; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET Pediatr Transplant; 2005 Apr; 9(2):178-82. PubMed ID: 15787789 [TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group. Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Halloran P; Mathew T; Tomlanovich S; Groth C; Hooftman L; Barker C Transplantation; 1997 Jan; 63(1):39-47. PubMed ID: 9000658 [TBL] [Abstract][Full Text] [Related]
19. Individualization of mycophenolate mofetil dose in renal transplant recipients. van Hest RM; Hesselink DA; Vulto AG; Mathot RA; van Gelder T Expert Opin Pharmacother; 2006 Mar; 7(4):361-76. PubMed ID: 16503809 [TBL] [Abstract][Full Text] [Related]
20. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation. Behrend M Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]